Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease

被引:29
|
作者
Ballestri, Stefano [1 ]
Mantovani, Alessandro [2 ]
Nascimbeni, Fabio [3 ]
Lugari, Simonetta [4 ]
Lonardo, Amedeo [3 ]
机构
[1] UOC Med, Azienda USL Modena, Osped Pavullo, Pavullo nel Frignano, MO, Italy
[2] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[3] UOC Med Ad Indirizzo Metabol Nutrizionist Modena, AOU Modena, Osped Civile Baggiovara, Modena, Italy
[4] Univ Modena & Reggio Emilia, Modena, Italy
关键词
bone mass density; cancer; cardiovascular system; endocrine system; large bowel; metabolic syndrome; PCOS; sarcopenia; uric acid; OBSTRUCTIVE SLEEP-APNEA; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; GROWTH-HORMONE REPLACEMENT; POLYCYSTIC-OVARY-SYNDROME; INDEPENDENT RISK-FACTOR; KOREA NATIONAL-HEALTH; SKELETAL-MUSCLE MASS; TERM-FOLLOW-UP; CARDIOVASCULAR-DISEASE;
D O I
10.4155/fmc-2019-0003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review article aims to synthesize the evidence regarding nonalcoholic fatty liver disease (NAFLD) as a systemic disorder. We critically discuss the metabolic syndrome and its components; the cardiovascular and the endocrine system; chronic respiratory disorders; the musculoskeletal system; the skin; and extrahepatic tumors. We conclude that, while some of these extra-hepatic conditions clearly predispose to the development of secondary forms of NAFLD (typically hypothyroidism-induced NAFLD), others result from pre-existent NAFLD (e.g., certain extra-hepatic tumors) and others (such as Type 2 Diabetes) have, with NAFLD, mutual and bidirectional associations. Analyzed data imply that NAFLD is not merely a hepatic disease. It is also and possibly more importantly, a systemic disorder requiring a special awareness, a multidisciplinary approach and a multidimensional vision.
引用
收藏
页码:2171 / 2192
页数:22
相关论文
共 50 条
  • [42] Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
    Samuel, Varman T.
    Shulman, Gerald I.
    CELL METABOLISM, 2018, 27 (01) : 22 - 41
  • [43] Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease
    Alvina
    UNIVERSA MEDICINA, 2009, 28 (03) : 139 - 145
  • [44] Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease
    Feng, Yue Ying
    Xu, Xiao Qin
    Ji, Chen Bo
    Shi, Chun Mei
    Guo, Xi Rong
    Fu, Jun Fen
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (06) : 1983 - 1997
  • [45] Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?
    Yusuf Yilmaz
    World Journal of Hepatology, 2012, (12) : 332 - 334
  • [46] The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease
    Velasco, Nicolas
    Contreras, Alvaro
    Grassi, Bruno
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (05): : 453 - 457
  • [47] Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
    Jiang, Hua
    Wang, Hui
    Guo, Yangfan
    Zhu, Yankun
    Dai, Hui
    Liang, Chenchen
    Gao, Jianpeng
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [48] Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
    Salamone, Federico
    Bugianesi, Elisabetta
    JOURNAL OF HEPATOLOGY, 2010, 53 (06) : 1146 - 1147
  • [49] Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease
    Ceutz, Frederik R.
    Christensen, Emilie E.
    Winther-Soerensen, Marie
    Vilstrup, Hendrik
    Holst, Jens J.
    Albrechtsen, Nicolai J. Wewer
    DIABETES, 2022, 71
  • [50] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
    Koo, Seung-Hoi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 210 - 215